CAD 0.04
(0.0%)
Year | Total Debt | Total Debt Growth |
---|---|---|
2022 | 6.37 Million CAD | 4.85% |
2021 | 6.08 Million CAD | 2.91% |
2020 | 5.91 Million CAD | 5.36% |
2019 | 5.61 Million CAD | 142.28% |
2018 | 2.31 Million CAD | 0.0% |
2017 | - CAD | -100.0% |
2016 | 374.64 Thousand CAD | 0.0% |
2015 | 374.64 Thousand CAD | 0.0% |
2014 | 374.64 Thousand CAD | 60.53% |
2013 | 233.38 Thousand CAD | 11.57% |
2012 | 209.18 Thousand CAD | 112.8% |
2011 | 98.3 Thousand CAD | 0.0% |
2010 | - CAD | 0.0% |
2009 | - CAD | 0.0% |
2008 | - CAD | 0.0% |
2007 | - CAD | 0.0% |
2006 | - CAD | 0.0% |
2005 | - CAD | -100.0% |
2004 | 11.49 Thousand CAD | 0.0% |
2003 | - CAD | 0.0% |
Year | Total Debt | Total Debt Growth |
---|---|---|
2023 Q3 | 5.8 Million CAD | -1.03% |
2023 Q2 | 5.86 Million CAD | -1.59% |
2023 Q1 | 5.96 Million CAD | 0.08% |
2022 Q1 | 6.08 Million CAD | 10.9% |
2022 FY | 6.37 Million CAD | 4.85% |
2022 Q4 | 5.95 Million CAD | -7.33% |
2022 Q3 | 6.43 Million CAD | -0.58% |
2022 Q2 | 6.46 Million CAD | 6.39% |
2021 Q2 | 6.64 Million CAD | 7.8% |
2021 Q4 | 5.48 Million CAD | -15.93% |
2021 Q3 | 6.52 Million CAD | -1.91% |
2021 FY | 6.08 Million CAD | 2.91% |
2021 Q1 | 6.16 Million CAD | 12.68% |
2020 Q4 | 5.47 Million CAD | -3.72% |
2020 FY | 5.91 Million CAD | 5.36% |
2020 Q1 | 5.08 Million CAD | -9.35% |
2020 Q2 | 5.57 Million CAD | 9.67% |
2020 Q3 | 5.68 Million CAD | 1.91% |
2019 Q1 | 3.04 Million CAD | 31.67% |
2019 Q4 | 5.61 Million CAD | 55.13% |
2019 Q2 | 3.51 Million CAD | 15.24% |
2019 Q3 | 3.61 Million CAD | 2.93% |
2019 FY | 5.61 Million CAD | 142.28% |
2018 FY | 2.31 Million CAD | 0.0% |
2018 Q1 | - CAD | 0.0% |
2018 Q2 | - CAD | 0.0% |
2018 Q3 | 718.56 Thousand CAD | 0.0% |
2018 Q4 | 2.31 Million CAD | 222.35% |
2017 Q1 | 427.73 Thousand CAD | 14.17% |
2017 FY | - CAD | -100.0% |
2017 Q4 | - CAD | 0.0% |
2017 Q2 | - CAD | -100.0% |
2017 Q3 | - CAD | 0.0% |
2016 Q4 | 374.64 Thousand CAD | 0.0% |
2016 Q1 | 374.64 Thousand CAD | 0.0% |
2016 Q2 | 374.64 Thousand CAD | 0.0% |
2016 Q3 | 374.64 Thousand CAD | 0.0% |
2016 FY | 374.64 Thousand CAD | 0.0% |
2015 Q3 | 374.64 Thousand CAD | 0.0% |
2015 Q4 | 374.64 Thousand CAD | 0.0% |
2015 Q1 | 374.64 Thousand CAD | 0.0% |
2015 Q2 | 374.64 Thousand CAD | 0.0% |
2015 FY | 374.64 Thousand CAD | 0.0% |
2014 FY | 374.64 Thousand CAD | 60.53% |
2014 Q3 | 374.64 Thousand CAD | 52.74% |
2014 Q4 | 374.64 Thousand CAD | 0.0% |
2014 Q1 | 239.23 Thousand CAD | 2.51% |
2014 Q2 | 245.28 Thousand CAD | 2.53% |
2013 FY | 233.38 Thousand CAD | 11.57% |
2013 Q4 | 233.38 Thousand CAD | 2.66% |
2013 Q3 | 227.33 Thousand CAD | 2.73% |
2013 Q1 | 215.23 Thousand CAD | 2.89% |
2013 Q2 | 221.28 Thousand CAD | 2.81% |
2012 FY | 209.18 Thousand CAD | 112.8% |
2012 Q2 | 180.63 Thousand CAD | 42.18% |
2012 Q1 | 127.04 Thousand CAD | 29.24% |
2012 Q4 | 209.18 Thousand CAD | 3.72% |
2012 Q3 | 201.67 Thousand CAD | 11.65% |
2011 Q3 | 100.97 Thousand CAD | 4.09% |
2011 FY | 98.3 Thousand CAD | 0.0% |
2011 Q4 | 98.3 Thousand CAD | -2.65% |
2011 Q2 | 97.01 Thousand CAD | 104.41% |
2011 Q1 | 47.45 Thousand CAD | 0.0% |
2010 Q1 | - CAD | 0.0% |
2010 Q3 | - CAD | 0.0% |
2010 FY | - CAD | 0.0% |
2010 Q4 | - CAD | 0.0% |
2010 Q2 | - CAD | 0.0% |
2009 Q1 | - CAD | 0.0% |
2009 Q4 | - CAD | 0.0% |
2009 Q3 | - CAD | 0.0% |
2009 FY | - CAD | 0.0% |
2009 Q2 | - CAD | 0.0% |
2008 FY | - CAD | 0.0% |
2008 Q4 | - CAD | 0.0% |
2008 Q1 | - CAD | 0.0% |
2008 Q2 | - CAD | 0.0% |
2007 Q3 | - CAD | 0.0% |
2007 Q4 | - CAD | 0.0% |
2007 Q1 | - CAD | 0.0% |
2007 FY | - CAD | 0.0% |
2007 Q2 | - CAD | 0.0% |
2006 Q2 | - CAD | 0.0% |
2006 FY | - CAD | 0.0% |
2006 Q4 | - CAD | 0.0% |
2006 Q3 | - CAD | 0.0% |
2006 Q1 | - CAD | 0.0% |
2005 Q2 | 11.49 Thousand CAD | 0.0% |
2005 Q1 | 11.49 Thousand CAD | 0.0% |
2005 Q4 | - CAD | 0.0% |
2005 FY | - CAD | -100.0% |
2004 Q3 | 13.89 Thousand CAD | 0.0% |
2004 Q4 | 11.49 Thousand CAD | -17.3% |
2004 FY | 11.49 Thousand CAD | 0.0% |
2003 FY | - CAD | 0.0% |
Name | Total Debt | Total Debt Difference |
---|---|---|
Aion Therapeutic Inc. | 826.47 Thousand CAD | -671.887% |
Ayurcann Holdings Corp. | 709.07 Thousand CAD | -799.686% |
Blueberries Medical Corp. | 12.8 Thousand CAD | -49723.586% |
The BC Bud Corporation | 229.35 Thousand CAD | -2681.458% |
BioNxt Solutions Inc. | 4.89 Million CAD | -30.348% |
Christina Lake Cannabis Corp. | 6.09 Million CAD | -4.647% |
Captor Capital Corp. | 6.71 Million CAD | 4.998% |
City View Green Holdings Inc. | 1.49 Million CAD | -325.7% |
1CM Inc. | 6.39 Million CAD | 0.231% |
Global Hemp Group Inc. | 3.55 Million CAD | -79.367% |
Greenway Greenhouse Cannabis Corporation | 16.02 Million CAD | 60.179% |
IM Cannabis Corp. | 13.78 Million CAD | 53.712% |
Lobe Sciences Ltd. | 332.64 Thousand CAD | -1817.813% |
Maple Leaf Green World Inc. | 2.47 Million CAD | -157.736% |
Mountain Valley MD Holdings Inc. | - CAD | -Infinity% |
Nextleaf Solutions Ltd. | 449.74 Thousand CAD | -1318.448% |
Ovation Science Inc. | 192.61 Thousand CAD | -3212.002% |
Pharmadrug Inc. | 1.76 Million CAD | -261.067% |
Captiva Verde Wellness Corp. | 191.7 Thousand CAD | -3227.741% |
RAMM Pharma Corp. | 405.14 Thousand CAD | -1474.619% |
RIV Capital Inc. | 6.59 Million CAD | 3.24% |
Revive Therapeutics Ltd. | 25.21 Thousand CAD | -25199.064% |
Red White & Bloom Brands Inc. | 262.13 Million CAD | 97.566% |
SLANG Worldwide Inc. | 29.86 Million CAD | 78.641% |
1933 Industries Inc. | 17.57 Million CAD | 63.694% |
Red Light Holland Corp. | 811.04 Thousand CAD | -686.565% |
Top Strike Resources Corp. | 13.29 Million CAD | 52.0% |
Xebra Brands Ltd. | - CAD | -Infinity% |
Adastra Holdings Ltd. | 3.58 Million CAD | -78.033% |